我要投票 BD碧迪在医疗器械行业中的票数:821
· 外 推 电 报 ·
2025-08-06 00:12:29 星期三

【BD碧迪是哪个国家的品牌?】

BD碧迪是什么牌子?「BD碧迪」是碧迪医疗器械(上海)有限公司旗下著名品牌。该品牌发源于美国,由创始人邓建民在2002-12-09期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力BD碧迪品牌出海!将品牌入驻外推网,定制BD碧迪品牌推广信息,可以显著提高BD碧迪产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

创于1897年美国,医疗器械行业知名品牌,专注于改进药物传输,专业研发、生产和销售医疗设备、医疗系统和试剂的医疗技术企业。

BD是一家全球化的医疗技术公司。BD在保护患者和医护人员安全、强化医学研究和临床实验室建设领域为行业所瞩目。公司提供创新的解决方案,以帮助推进医学和基因组学研究、加强传染性疾病和癌症的诊断、改善药物管理、促进感染预防、为手术和介入治疗提供工具,并支持糖尿病管理。

1897年,秉承改善患者医疗结果的信念,Maxwell Becton和Fairleigh Dickinson创立了BD公司。历经一个多世纪的不断探索,BD在保护患者和医护人员安全方面拥有丰富的经验和雄厚的实力,并能够为医学研究和临床试验提供技术支持。

BD将成为一家更以客户为中心的企业,与客户及合作伙伴紧密协作,帮助改善医疗结果,降低医疗护理成本,提升效率,保护患者和医护人员安全并增加医疗可及性。

BD在中国发展迅速,目前成立了以上海为BD中国区总部,北京、广州、成都等十五个办事处为核心的业务格局,带动辐射全国,拥有员工近3,000人。

BD中国的业务分为两大板块:BD医疗(BD Medical)和 BD生命科学(BD Life Science)。


英文翻译:Founded in the United States in 1897, it is a well-known brand in the medical device industry. It is a medical technology enterprise specializing in the improvement of drug delivery and the research, development, production and sales of medical equipment, medical systems and reagents. BD is a global medical technology company. BD has attracted the attention of the industry in the fields of protecting the safety of patients and medical staff, strengthening medical research and clinical laboratory construction. The company provides innovative solutions to help advance medical and genomic research, enhance the diagnosis of infectious diseases and cancer, improve drug management, promote infection prevention, provide tools for surgery and interventional treatment, and support diabetes management. In 1897, Maxwell Becton and Fairleigh Dickinson founded BD company with the belief of improving the medical results of patients. After more than a century of continuous exploration, BD has rich experience and strength in protecting the safety of patients and medical staff, and can provide technical support for medical research and clinical trials. BD will become a more customer-centric enterprise, working closely with customers and partners to help improve medical results, reduce medical care costs, improve efficiency, protect patients and medical staff safety and increase medical access. BD has developed rapidly in China. At present, it has established a business pattern with Shanghai as its headquarters in China and 15 offices in Beijing, Guangzhou and Chengdu as its core, which has led to radiation across the country, with nearly 3000 employees. BD China's business is divided into two parts: BD medical and BD life science.

本文链接: https://www.waitui.com/brand/1cf137415.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

Palantir季度营收首破10亿美元大关,上调2025全年业绩指引

数据挖掘公司Palantir在人工智能热潮中再创佳绩:季度营收首次突破10亿美元大关,同比激增48%至10亿美元;调整后每股收益0.16美元,两项数据均超市场预期。公司同时将2025全年营收预期上调至41.42-41.50亿美元,显著高于此前指引。(新浪财经)

13分钟前

特朗普:将在未来24小时内大幅提高印度关税

据报道,美国总统特朗普表示,将在未来24小时内大幅提高印度关税。(界面)

13分钟前

美股大型科技股盘前多数上涨,亚马逊涨0.67%

36氪获悉,美股大型科技股盘前多数上涨,截至发稿,亚马逊涨0.67%,微软涨0.54%,英伟达涨0.37%,特斯拉涨0.23%,苹果涨0.21%,奈飞涨0.16%,谷歌涨0.14%;Meta跌0.05%。

13分钟前

热门中概股美股盘前多数上涨,哔哩哔哩涨超3%

36氪获悉,热门中概股美股盘前多数上涨,截至发稿,哔哩哔哩涨超3%,理想汽车涨超2%,蔚来、网易、富途控股、腾讯音乐涨超1%,小鹏汽车涨近1%;京东跌0.73%,百度跌0.43%。

13分钟前

石药集团:司美格鲁肽注射液上市申请获国家药监局受理

36氪获悉,石药集团发布公告,附属公司石药集团百克(山东)生物制药股份有限公司开发的司美格鲁肽注射液的上市申请已获国家药品监督管理局受理。本次申报的适应症为成人2型糖尿病患者的血糖控制。

13分钟前

本页详细列出关于BD碧迪的品牌信息,含品牌所属公司介绍,BD碧迪所处行业的品牌地位及优势。
咨询